Congwei Luo

1.3k total citations
22 papers, 1.0k citations indexed

About

Congwei Luo is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Congwei Luo has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 11 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Congwei Luo's work include Chronic Kidney Disease and Diabetes (6 papers), Parathyroid Disorders and Treatments (5 papers) and Dialysis and Renal Disease Management (4 papers). Congwei Luo is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Parathyroid Disorders and Treatments (5 papers) and Dialysis and Renal Disease Management (4 papers). Congwei Luo collaborates with scholars based in China and United States. Congwei Luo's co-authors include Lili Zhou, Youhua Liu, Fan Fan Hou, Yahong Liu, Hongyan Li, Jiafeng Liu, Yunfang Zhang, Haibo Long, Fenfen Peng and Jinhua Miao and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and The FASEB Journal.

In The Last Decade

Congwei Luo

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Congwei Luo China 16 529 272 211 126 113 22 1.0k
Hongdi Cao China 17 496 0.9× 347 1.3× 186 0.9× 74 0.6× 122 1.1× 21 919
Zhengzhe Li China 19 471 0.9× 359 1.3× 110 0.5× 155 1.2× 97 0.9× 33 1.1k
Jinhua Miao China 18 623 1.2× 484 1.8× 105 0.5× 147 1.2× 162 1.4× 30 1.3k
Weier Qi Australia 23 637 1.2× 306 1.1× 97 0.5× 117 0.9× 164 1.5× 28 1.3k
Suozhu Shi China 17 411 0.8× 206 0.8× 187 0.9× 105 0.8× 217 1.9× 39 1.1k
Yan Dai China 15 431 0.8× 295 1.1× 128 0.6× 126 1.0× 70 0.6× 27 884
Wenqi Ma China 21 581 1.1× 153 0.6× 331 1.6× 99 0.8× 127 1.1× 47 1.2k
Takashi Dan Japan 17 289 0.5× 220 0.8× 265 1.3× 96 0.8× 158 1.4× 51 1.1k
Shaoqun Shu China 15 545 1.0× 409 1.5× 198 0.9× 109 0.9× 136 1.2× 17 1.3k
Gábor Kökény Hungary 18 435 0.8× 222 0.8× 106 0.5× 100 0.8× 124 1.1× 36 1.0k

Countries citing papers authored by Congwei Luo

Since Specialization
Citations

This map shows the geographic impact of Congwei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congwei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congwei Luo more than expected).

Fields of papers citing papers by Congwei Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Congwei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congwei Luo. The network helps show where Congwei Luo may publish in the future.

Co-authorship network of co-authors of Congwei Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Congwei Luo. A scholar is included among the top collaborators of Congwei Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Congwei Luo. Congwei Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xiaoyang, Xiaowen Chen, Wenting Wu, et al.. (2025). Ovatodiolide alleviates renal fibrosis through regulating metabolic reprogramming via targeting glucose-6-phosphate dehydrogenase. Phytomedicine. 145. 156983–156983.
2.
Li, Shuting, Yue Ji, Xiaowen Chen, et al.. (2024). BRG1 accelerates mesothelial cell senescence and peritoneal fibrosis by inhibiting mitophagy through repression of OXR1. Free Radical Biology and Medicine. 214. 54–68. 4 indexed citations
3.
Mo, Min, Shuting Li, Xiaoyang He, et al.. (2023). N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway. Chemico-Biological Interactions. 382. 110589–110589. 5 indexed citations
4.
Li, Shuting, Congwei Luo, Sijia Chen, et al.. (2023). Brahma-related gene 1 acts as a profibrotic mediator and targeting it by micheliolide ameliorates peritoneal fibrosis. Journal of Translational Medicine. 21(1). 639–639. 6 indexed citations
5.
Li, Yaqin, et al.. (2023). Renal Fibrosis Is Alleviated through Targeted Inhibition of IL-11–Induced Renal Tubular Epithelial-to-Mesenchymal Transition. American Journal Of Pathology. 193(12). 1936–1952. 17 indexed citations
6.
Chen, Xiaowen, Jing Xiao, Sijia Chen, et al.. (2023). Metadherin orchestrates PKA and PKM2 to activate β-catenin signaling in podocytes during proteinuric chronic kidney disease. Translational research. 266. 68–83. 4 indexed citations
7.
Wu, Na, Sijia Chen, Fenfen Peng, et al.. (2023). The relationship between decline rate of residual renal function in the first year and mortality in peritoneal dialysis patients. Therapeutic Apheresis and Dialysis. 28(2). 255–264. 1 indexed citations
8.
Miao, Jinhua, Jiewu Huang, Congwei Luo, et al.. (2021). Klotho retards renal fibrosis through targeting mitochondrial dysfunction and cellular senescence in renal tubular cells. Physiological Reports. 9(2). e14696–e14696. 50 indexed citations
9.
Chen, Xiaowen, Wenting Liu, Jing Xiao, et al.. (2020). FOXO3a accumulation and activation accelerate oxidative stress‐induced podocyte injury. The FASEB Journal. 34(10). 13300–13316. 26 indexed citations
10.
Peng, Fenfen, Wangqiu Gong, Shuting Li, et al.. (2020). circRNA_010383 Acts as a Sponge for miR-135a, and Its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy. Diabetes. 70(2). 603–615. 97 indexed citations
11.
Peng, Fenfen, Wangqiu Gong, Shu‐Ting Li, et al.. (2020). circRNA_010383 Acts as a Sponge for miR-135a and its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy. Diabetes. 70(2). db200203–db200203. 85 indexed citations
12.
Miao, Jinhua, Jiafeng Liu, Jing Niu, et al.. (2019). Wnt/β‐catenin/RAS signaling mediates age‐related renal fibrosis and is associated with mitochondrial dysfunction. Aging Cell. 18(5). e13004–e13004. 207 indexed citations
13.
Li, Shuting, Fenfen Peng, Wangqiu Gong, et al.. (2019). Dimethylaminomicheliolide ameliorates peritoneal fibrosis through the activation of autophagy. Journal of Molecular Medicine. 97(5). 659–674. 21 indexed citations
14.
Li, Peilin, Yuxian Wang, Shuting Li, et al.. (2019). MicroRNA-145 promotes the epithelial-mesenchymal transition in peritoneal dialysis-associated fibrosis by suppressing fibroblast growth factor 10. Journal of Biological Chemistry. 294(41). 15052–15067. 20 indexed citations
15.
Liu, Wenting, Xiaowen Chen, Yuxian Wang, et al.. (2019). Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice. Pharmacological Research. 150. 104506–104506. 41 indexed citations
16.
Zhang, Ying, Yihua Chen, Yuxian Wang, et al.. (2019). Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway. International Immunopharmacology. 78. 106064–106064. 41 indexed citations
17.
Peng, Fenfen, Hongyu Li, Shuting Li, et al.. (2019). Micheliolide ameliorates renal fibrosis by suppressing the Mtdh/BMP/MAPK pathway. Laboratory Investigation. 99(8). 1092–1106. 30 indexed citations
18.
Luo, Congwei, Shan Zhou, Zhanmei Zhou, et al.. (2018). Wnt9a Promotes Renal Fibrosis by Accelerating Cellular Senescence in Tubular Epithelial Cells. Journal of the American Society of Nephrology. 29(4). 1238–1256. 203 indexed citations
19.
Chen, Shuangqin, Haiyan Fu, Wenjuan Zhu, et al.. (2018). Tenascin-C protects against acute kidney injury by recruiting Wnt ligands. Kidney International. 95(1). 62–74. 41 indexed citations
20.
Mo, Hongyan, Qinyu Wu, Jinhua Miao, et al.. (2016). C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury. Antioxidants and Redox Signaling. 27(6). 345–362. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongdi Cao Breakdown of academic impact, for papers by Zhengzhe Li Breakdown of academic impact, for papers by Jinhua Miao Breakdown of academic impact, for papers by Weier Qi Breakdown of academic impact, for papers by Suozhu Shi Breakdown of academic impact, for papers by Yan Dai Breakdown of academic impact, for papers by Wenqi Ma Breakdown of academic impact, for papers by Takashi Dan Breakdown of academic impact, for papers by Shaoqun Shu Breakdown of academic impact, for papers by Gábor Kökény
Rankless by CCL
2026